Status:

COMPLETED

Validation of RDQ Questionnaire

Lead Sponsor:

AstraZeneca

Conditions:

Gastroesophageal Reflux

Eligibility:

All Genders

18-79 years

Phase:

PHASE4

Brief Summary

The primary objective of this study is to determine the accuracy of the Reflux Disease Questionnaire (RDQ) as a diagnostic test for gastroesophageal reflux disease. Symptom evaluation by the RDQ will ...

Eligibility Criteria

Inclusion

  • Subjects who seek medical advice at their family doctor (primary care physician) for symptoms thought by the primary care physician to arise from the upper GI tract
  • The symptoms thought to pertain to the upper GI tract must have been present for at least 4 weeks prior to Visit 1 and to have occurred at least twice a week during that period
  • The symptoms thought to pertain to the upper GI tract must have been of at least mild severity for a minimum of 3 days during the week prior to Visit 1

Exclusion

  • Upper GI endoscopy performed within a year prior to Visit 1
  • Previous anti-reflux surgery, surgery for peptic ulcer or any form of upper gastrointestinal resective surgery
  • Contra-indication to the Bravo™ procedure such as subjects with a history of bleeding diathesis, strictures anywhere along the GI-tract, esophageal varices, obstructions, or subjects equipped with a pacemaker, an implantable cardiac defibrillator or an implantable neurostimulator (NB: subjects with severe esophagitis (grade D) confirmed by endoscopy at Visit 2 can continue the study without performing the Bravo™ procedure)

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

End Date :

November 1 2006

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT00291746

Start Date

September 1 2005

End Date

November 1 2006

Last Update

March 12 2009

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

Research Site

Etobicoke, Ontario, Canada

2

Research Site

Hamilton, Ontario, Canada

3

Research Site

North York, Ontario, Canada

4

Research Site

Mirabel, Quebec, Canada